Pharmaceuticals, Biotechnology and Life Sciences
At final analysis, study showed clinically relevant improvement in median overall survival with a difference of 11.7 months between arms…
– In pivotal Phase 3 JUPITER-02 study, toripalimab plus chemotherapy significantly improved PFS compared to chemotherapy alone in high and…
– Data being presented show long-term benefits of Bylvay in children with PFIC – – First potential non-invasive treatment option…
SHANGHAI, China, June 04, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions…
First patient dosed by Vincerx marks significant milestone in Company’s developmentPALO ALTO, Calif., June 03, 2021 (GLOBE NEWSWIRE) — Vincerx…
Company announcement – No. 36/ 2021 Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference Copenhagen, DK…
NEW HAVEN, Conn., June 03, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a pre-clinical,…
Basking Ridge, NJ, June 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE…
DUBLIN, Ireland and TREVOSE, Pa., June 03, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical…
CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a…